ChemoCentryx and VFMCRP Announce Positive Topline Data from Pivotal Phase III ADVOCATE Trial Demonstrating Avacopan’s Superiority Over Standard of Care in ANCA-Associated Vasculitis

Ads

You May Also Like

Notification from Oasmia Pharmaceutical AB

Oasmia Pharmaceutical AB hereby issues a notification that the Company has submitted a Form ...

Cyclacel Pharmaceuticals to Present at the Noble Capital Markets Investor Conference

BERKELEY HEIGHTS, N.J., Jan. 24, 2018 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) (NASDAQ:CYCCP) ...

Houston Dermatologist Reveals Laser Treatment Options for Birthmarks

HOUSTON, Jan. 04, 2018 (GLOBE NEWSWIRE) -- Most birthmarks, including Becker’s Nevus and Nevus ...